Skip to content
Independent analysis of NHS open data
PharmaInsight

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide vs Oseltamivir phosphate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated January 2026

Oseltamivir phosphate was dispensed 112.0× as often as Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide in January 2026 — 336 items versus 3 in England.

3items

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide · January 2026

NHSBSA Prescription Cost Analysis

336items

Oseltamivir phosphate · January 2026

NHSBSA Prescription Cost Analysis

Figure 1. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Oseltamivir phosphate: national items dispensed by month

▬ Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide   ·   ╌ Oseltamivir phosphate

0 8k 15k Jan 2026 Oseltamivir phos… 3 Jan 2026: 3

Source: NHSBSA Prescription Cost Analysis, to January 2026

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Oseltamivir phosphate, January 2026
Measure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Oseltamivir phosphate
Items, January 2026 3 336
Items, last 12 months 3 37,292
Net ingredient cost, January 2026 £88 £5,074

See the full profile for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide or Oseltamivir phosphate.